Resistell News:

The imperative of ultra-rapid Antibiotic Susceptibility Testing

The imperative of ultra-rapid Antibiotic Susceptibility Testing
Resistell News:

The imperative of ultra-rapid Antibiotic Susceptibility Testing

Antibiotic treatments are often preemptively initiated without knowing the antibiotic resistance profile of the causative pathogen. This leads to potentially inappropriate therapies. Ultra-rapid Antibiotic Susceptibility Testing (AST) is key in identifying the effective antibiotics, and here are compelling reasons for healthcare providers to prioritize it.

More
The imperative of ultra-rapid Antibiotic Susceptibility Testing

Latest news

ARTE TV: Nano-motion device invented by Sandor Kasas and Giovanni Dietler from EPFL to be used to search for life on other planets?
30th August 2019

ARTE TV: Nano-motion device invented by Sandor Kasas and Giovanni Dietler from EPFL to be used to search for life on other planets?

In the immensity of the cosmos, could life develop on another planet than Earth? Nano-motion device invented be Sandor Kasas and Giovanni Dietler from EPFL Lausanne...
More
Resistell - the winner of the Pitch Night Boston 2019: The Future of HealthTech!
13th June 2019

Resistell - the winner of the Pitch Night Boston 2019: The Future of HealthTech!

Thank you for giving us the opportunity to take part in the Pitch Night Boston 2019: The Future of HealthTech and to present our rapid AST.
More
Resistell at Boston Pitch Night 2019: The Future of HealthTech
Wikipedia
12th June 2019

Resistell at Boston Pitch Night 2019: The Future of HealthTech

Join Resistell at OBERON to see our Rapid AST solution at Pitch Night 2019, where 10 of Switzerland’s most promising young HealthTech startups will pitch their ideas alongside their counterparts from North America, including some of the Boston area’s favorite early Life Sciences startups.
More
Symposium on Rapid AST in Uppsala
29th May 2019

Symposium on Rapid AST in Uppsala

We would like to thank the colleagues from the Uppsala Antibiotic Centre for the invitation to an excellent Symposium on Rapid ASTs. We are impressed by the quality of the event, participants and the discussions and honoured to be an invited speaker.
More
Ten Venture Leaders will represent Switzerland in Boston in June. Meet us there!
17th May 2019

Ten Venture Leaders will represent Switzerland in Boston in June. Meet us there!

Learn more on rapid phenotypic antibiotic susceptibility test and Danuta's expectations on her roadshow in Boston.
More